{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:09:16Z","timestamp":1790438956603,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0011265","type":"journal-article","created":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T19:59:14Z","timestamp":1277236754000},"page":"e11265","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cell Type Mediated Resistance of Vesicular Stomatitis Virus and Sendai Virus to Ribavirin"],"prefix":"10.1371","volume":"5","author":[{"given":"Nirav R.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery Z.","family":"Grdzelishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.","volume":"177","author":"RW Sidwell","year":"1972","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2004.11.006","article-title":"Metabolism and antiviral activity of ribavirin.","volume":"107","author":"WB Parker","year":"2005","journal-title":"Virus Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1440-1746.2008.05398.x","article-title":"Ribavirin in the treatment of chronic hepatitis C.","volume":"23","author":"P Martin","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s00018-005-5455-y","article-title":"The metabolism, pharmacokinetics and mechanisms of antiviral activity of ribavirin against hepatitis C virus.","volume":"63","author":"NM Dixit","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.11.007","article-title":"Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications.","volume":"107","author":"M Vignuzzi","year":"2005","journal-title":"Virus Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/CMR.00010-06","article-title":"Viral determinants of resistance to treatment in patients with hepatitis C.","volume":"20","author":"A Wohnsland","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/JVI.77.10.5933-5947.2003","article-title":"Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.","volume":"77","author":"Y Zhang","year":"2003","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/AAC.47.7.2293-2298.2003","article-title":"Synergistic in vitro interactions between alpha interferon and ribavirin against bovine viral diarrhea virus and yellow fever virus as surrogate models of hepatitis C virus replication.","volume":"47","author":"VE Buckwold","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1073\/pnas.75.7.3042","article-title":"Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line.","volume":"75","author":"RC Willis","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"24591","DOI":"10.1016\/S0021-9258(19)74507-4","article-title":"Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.","volume":"268","author":"J Balzarini","year":"1993","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1128\/AAC.49.6.2164-2171.2005","article-title":"Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5\u2032-nucleotidase II: Implications for ribavirin metabolism in erythrocytes.","volume":"49","author":"JZ Wu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity.","volume":"100","author":"JK Pfeiffer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0042-6822(03)00144-2","article-title":"Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis.","volume":"311","author":"A Airaksinen","year":"2003","journal-title":"Virology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1128\/JVI.01606-06","article-title":"Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe.","volume":"81","author":"M Sierra","year":"2007","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1128\/JVI.79.4.2346-2355.2005","article-title":"Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.","volume":"79","author":"JK Pfeiffer","year":"2005","journal-title":"J Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1128\/JVI.02280-08","article-title":"Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.","volume":"83","author":"KD Ibarra","year":"2009","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1128\/AAC.29.6.1010","article-title":"Effect of ribavirin on macromolecular synthesis in vesicular stomatitis virus-infected cells.","volume":"29","author":"P Toltzis","year":"1986","journal-title":"AntimicrobAgents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/AAC.32.4.492","article-title":"Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription.","volume":"32","author":"P Toltzis","year":"1988","journal-title":"AntimicrobAgents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1567-1348(04)00064-4","article-title":"Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.","volume":"5","author":"JM Cuevas","year":"2005","journal-title":"Infect Genet Evol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000221861","article-title":"In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections.","volume":"21","author":"RW Sidwell","year":"1975","journal-title":"Chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.10.4.770","article-title":"Therapeutic effects of small-particle aerosols of ribavirin on parainfluenza (sendai) virus infections of mice.","volume":"10","author":"EW Larson","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JVI.73.1.251-259.1999","article-title":"Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.","volume":"73","author":"UJ Buchholz","year":"1999","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1128\/JVI.00211-06","article-title":"Visualization of intracellular transport of vesicular stomatitis virus nucleocapsids in living cells.","volume":"80","author":"SC Das","year":"2006","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1128\/JVI.00914-07","article-title":"De novo synthesis of N and P proteins as a key step in Sendai virus gene expression.","volume":"81","author":"MA Wiegand","year":"2007","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1743-422X-3-63","article-title":"New low-viscosity overlay medium for viral plaque assays.","volume":"3","author":"M Matrosovich","year":"2006","journal-title":"Virol J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1016\/S0021-9258(18)34138-3","article-title":"Complete analysis of cellular nucleotides by two-dimensional thin layer chromatography.","volume":"257","author":"BR Bochner","year":"1982","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1128\/JVI.01438-08","article-title":"Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.","volume":"83","author":"AM Murphy","year":"2009","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9044-4","article-title":"The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs.","volume":"26","author":"J Zhang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2010.01.011","article-title":"Characterization of ribavirin uptake systems in human hepatocytes.","volume":"52","author":"Y Fukuchi","year":"2010","journal-title":"J Hepatol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.","volume":"79","author":"P Leyssen","year":"2005","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.00790-06","article-title":"Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5\u2032-triphosphate, not with inhibition of IMP dehydrogenase.","volume":"51","author":"Y Sun","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0166-3542(85)90012-9","article-title":"Mode of action of ribavirin: effect of nucleotide pool alterations on influenza virus ribonucleoprotein synthesis.","volume":"5","author":"SK Wray","year":"1985","journal-title":"Antiviral Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/AAC.30.1.117","article-title":"Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells.","volume":"30","author":"DF Smee","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0042-6822(80)90117-8","article-title":"Inhibition of Sindbis virus replication in Aedes albopictus cells by virazole (ribavirin) and its reversal by actinomycin: a correction.","volume":"102","author":"F Malinoski","year":"1980","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/AAC.21.1.66","article-title":"Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity.","volume":"21","author":"DF Smee","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1128\/JVI.73.9.7903-7906.1999","article-title":"Inhibition of Borna disease virus replication by ribavirin.","volume":"73","author":"I Jordan","year":"1999","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00109-001-0308-0","article-title":"Ribavirin's antiviral mechanism of action: lethal mutagenesis?","volume":"80","author":"S Crotty","year":"2002","journal-title":"J Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/AAC.17.5.770","article-title":"Effects of ribavirin on respiratory syncytial virus in vitro.","volume":"17","author":"JF Hruska","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.antiviral.2007.09.004","article-title":"In vitro efficacy of ribavirin against canine distemper virus.","volume":"77","author":"G Elia","year":"2008","journal-title":"Antiviral Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.healun.2008.10.008","article-title":"Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection.","volume":"28","author":"A Pelaez","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"ref41","first-page":"17","article-title":"The clinical pharmacology of ribavirin.","volume":"19","author":"P Glue","year":"1999","journal-title":"Semin Liver Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/135965350801300401","article-title":"Prediction of sustained virological response by ribavirin plasma concentration at week 4 of therapy in hepatitis C virus genotype 1 patients.","volume":"13","author":"M Maynard","year":"2008","journal-title":"Antivir Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.22217","article-title":"Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.","volume":"47","author":"V Loustaud-Ratti","year":"2008","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dkn013","article-title":"The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV\/HCV-co-infected patients treated with ribavirin and pegylated interferon.","volume":"61","author":"D Aguilar Marucco","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.00201-09","article-title":"Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo.","volume":"83","author":"JM Cuevas","year":"2009","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.bjp.0701775","article-title":"Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters.","volume":"123","author":"SM Jarvis","year":"1998","journal-title":"Br J Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/jac\/dki405","article-title":"Treating HCV with ribavirin analogues and ribavirin-like molecules.","volume":"57","author":"RG Gish","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0020-711X(90)90140-X","article-title":"The metabolism of ribavirin in erythrocytes and nucleated cells.","volume":"22","author":"T Page","year":"1990","journal-title":"Int J Biochem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.108.145854","article-title":"The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1\u2212\/\u2212 mouse erythrocytes.","volume":"329","author":"CJ Endres","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0011265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T18:15:55Z","timestamp":1685643355000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0011265"}},"subtitle":[],"editor":[{"given":"Ron A. M.","family":"Fouchier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,6,22]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0011265","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,22]]}}}